In 2010, a milestone was achieved when the first patient with cancer was treated with CAR-T-cell therapy. This pioneering treatment modifies a patient's T cells by inserting a gene for a chimeric ...
For the first time, researchers have used lab-grown organoids created from tumors of individuals with glioblastoma (GBM) to accurately model a patient's response to CAR T cell therapy in real time.